Reducing opioid. analgesic abuse: models for successful collaboration among government, industry and other key stakeholders.
Smith
Meredith Y
MY
Kleber
Herbert D
HD
Katz
Nathanial
N
Houck
Larry K
LK
Sabo
Alex
A
D000701:Analgesics, Opioid / Q000627:therapeutic use; D003299:Cooperative Behavior; D004345:Drug Industry; D011307:Drug Prescriptions; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D009602:Nitrosamines; D009293:Opioid-Related Disorders / Q000517:prevention & control*; D010146:Pain / Q000188:drug therapy; D012308:Risk Management; D014481:United States; D014486:United States Food and Drug Administration
D000701:Analgesics, Opioid; D009602:Nitrosamines; C048588:N-nitrosoiminodiacetic acid